Highlights
ASX: LCT       LIVING CELL TECHNOLOGIES LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.023   0.00 (0.00%)  0.023 - 0.023  10,100

Overview

 
Avg Volume (4 weeks):277,147
4 Weeks Range:0.022 - 0.031
4 Weeks Price Volatility (%):
11.11%
52 Weeks Range:0.02 - 0.083
52 Weeks Price Volatility (%):
4.76%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Living Cell Technologies Limited is a biotechnology company, which is engaged in discovering, developing and commercializing regenerative treatments, which use naturally occurring cells to restore function. The Company operates through the segment of research and development into living cell technologies, predominantly in New Zealand. Its product pipeline consists of cell therapies developed from cells sourced from a herd of disease-free pigs breed from stock originally discovered in the remote sub-Antarctic Auckland Islands. The Company's treatments are based on cell encapsulation and implantation for human therapeutics. The Company's products are NTCELL and DIABECELL. NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. DIABECELL is an insulin-producing cell product derived from pigs for the treatment of type I diabetes. It completed Phase I/IIa clinical trial for NTCELL for Parkinson's disease.

  Be the first to like this.
 


 

706  568  682  9162 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 PNX 0.008+0.003 
 SCG 3.97+0.06 
 TV2 0.011+0.001 
 CMW 1.16-0.095 
 VML 0.0120.00 
 BRN 0.076-0.018 
 BLK 0.0120.00 
 BUB 1.225+0.295 
 ADNOB 0.007-0.001 
 ADN 0.016-0.001 
Partners & Brokers